Your session is about to expire
← Back to Search
Antifungal
UHE-103 Cream for Athlete's Foot
Phase 1
Waitlist Available
Research Sponsored by Therapeutics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 16
Awards & highlights
Summary
This trial is testing a new cream (UHE 103) against an existing one (Naftin) in people with jock itch or athlete's foot. The creams aim to treat these fungal infections by killing or stopping the fungus. Naftin is known for its effectiveness in treating various superficial infections, providing both antifungal action and relief from inflammation.
Eligible Conditions
- Jock Itch
- Athlete's Foot
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ day 16
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 16
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
AUC (0-12 hours)
Adverse Events (AEs)
Local Skin Reactions (LSRs)
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: UHE-103 CreamExperimental Treatment1 Intervention
Subjects will apply at least a total of 4 grams\* of the test article, covering both feet twice daily for 2 weeks
Group II: Naftin (naftifine hydrochloride) Cream, 2%Active Control1 Intervention
Subjects will apply at least a total of 5 grams\* of the test article, covering the interdigital areas of both feet and to the groin once daily for 2 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
UHE-103 Cream
2022
Completed Phase 1
~50
Find a Location
Who is running the clinical trial?
Therapeutics, Inc.Lead Sponsor
30 Previous Clinical Trials
3,870 Total Patients Enrolled
Tony AndrasfayStudy DirectorTherapeutics Inc. (CRO)
6 Previous Clinical Trials
520 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger